183 related articles for article (PubMed ID: 26311046)
1. A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.
Seibert JK; Quagliata L; Quintavalle C; Hammond TG; Terracciano L; Odermatt A
Cancer Med; 2015 Nov; 4(11):1717-29. PubMed ID: 26311046
[TBL] [Abstract][Full Text] [Related]
2. The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples.
Stücheli S; Araya S; Ercan C; Moser SO; Gallon J; Jenö P; Piscuoglio S; Terracciano L; Odermatt A
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804847
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
5. Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.
Obinata D; Takada S; Takayama K; Urano T; Ito A; Ashikari D; Fujiwara K; Yamada Y; Murata T; Kumagai J; Fujimura T; Ikeda K; Horie-Inoue K; Homma Y; Takahashi S; Inoue S
Eur J Cancer; 2016 Apr; 57():39-49. PubMed ID: 26854828
[TBL] [Abstract][Full Text] [Related]
6. DHRS7 (SDR34C1) - A new player in the regulation of androgen receptor function by inactivation of 5α-dihydrotestosterone?
Araya S; Kratschmar DV; Tsachaki M; Stücheli S; Beck KR; Odermatt A
J Steroid Biochem Mol Biol; 2017 Jul; 171():288-295. PubMed ID: 28457967
[TBL] [Abstract][Full Text] [Related]
7. Reduction in Nuclear Size by DHRS7 in Prostate Cancer Cells and by Estradiol Propionate in DHRS7-Depleted Cells.
Rizzotto A; Tollis S; Pham NT; Zheng Y; Abad MA; Wildenhain J; Jeyaprakash AA; Auer M; Tyers M; Schirmer EC
Cells; 2023 Dec; 13(1):. PubMed ID: 38201261
[TBL] [Abstract][Full Text] [Related]
8. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
[TBL] [Abstract][Full Text] [Related]
9. STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.
Burnell SEA; Spencer-Harty S; Howarth S; Bodger O; Kynaston H; Morgan C; Doak SH
Sci Rep; 2018 Apr; 8(1):6252. PubMed ID: 29674723
[TBL] [Abstract][Full Text] [Related]
10. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
11. Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.
Hoyne G; Rudnicka C; Sang QX; Roycik M; Howarth S; Leedman P; Schlaich M; Candy P; Matthews V
BMC Cancer; 2016 Feb; 16():151. PubMed ID: 26912236
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
14. Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.
Goto K; Oue N; Hayashi T; Shinmei S; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
Pathobiology; 2014; 81(4):190-8. PubMed ID: 25170626
[TBL] [Abstract][Full Text] [Related]
15. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.
Yu S; Wang Y; Yuan H; Zhao H; Lv W; Chen J; Wan F; Liu D; Gao Z; Wu J
PLoS One; 2017; 12(1):e0171134. PubMed ID: 28125713
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
19. Purification and reconstitution of human membrane-bound DHRS7 (SDR34C1) from Sf9 cells.
Skarka A; Škarydová L; Štambergová H; Wsól V
Protein Expr Purif; 2014 Mar; 95():44-9. PubMed ID: 24316191
[TBL] [Abstract][Full Text] [Related]
20. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia.
Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H
Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
